H T Cueto1, A H Riis1, E E Hatch2, L A Wise2,3, K J Rothman1,2,4, H T Sørensen1,2, E M Mikkelsen1. 1. Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark. 2. Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA. 3. Slone Epidemiology Center, Boston University, Boston, MA, USA. 4. RTI International, Research Triangle Park, NC, USA.
Abstract
BACKGROUND/ OBJECTIVES: Periconceptional folic acid (FA) supplementation reduces the risk of neural tube defects and has been associated with ovulatory function. However, only two studies have associated supplementation with multivitamins (MVs) that contained FA with increased pregnancy rates. We aimed to examine the association between FA supplementation (obtained either through single FA tablets or through MVs) and fecundability. SUBJECTS/ METHODS: A prospective cohort study of 3895 Danish women who were planning a pregnancy between 2007 and 2011. We estimated fecundability ratios (FRs) and 95% confidence intervals (CIs) in relation to FA supplementation (either through single FA tablets or MV) using a proportional probabilities regression model, with adjustment for potential socio-demographic, reproductive and lifestyle confounders. In stratified analyses, we also estimated FR with 95% CI in relation to FA supplementation for women with regular and irregular cycles, respectively, and for women with short (<27 days), medium (27-29 days) and long cycles (⩾30 days), respectively. RESULTS: FA supplementation was associated with increased fecundability (FR=1.15, 95% CI=1.06-1.25), compared with non-use. The adjusted FRs for FA supplement use relative to non-use were 1.35 (95% CI=1.12-1.65) and 1.11 (95% CI=1.01-1.22) for women with irregular and regular cycles, respectively, and 1.36 (95% CI=0.95-1.95), 1.10 (95% CI=0.98-1.22) and 1.24 (95% CI=1.10-1.41) for women with short (<27 days), medium (27-29 days) and long cycles (⩾30 days), respectively. CONCLUSIONS: FA supplementation was associated with increased fecundability, and this association appeared to be stronger among women with irregular cycles and among women with either short or long cycle length.
BACKGROUND/ OBJECTIVES: Periconceptional folic acid (FA) supplementation reduces the risk of neural tube defects and has been associated with ovulatory function. However, only two studies have associated supplementation with multivitamins (MVs) that contained FA with increased pregnancy rates. We aimed to examine the association between FA supplementation (obtained either through single FA tablets or through MVs) and fecundability. SUBJECTS/ METHODS: A prospective cohort study of 3895 Danish women who were planning a pregnancy between 2007 and 2011. We estimated fecundability ratios (FRs) and 95% confidence intervals (CIs) in relation to FA supplementation (either through single FA tablets or MV) using a proportional probabilities regression model, with adjustment for potential socio-demographic, reproductive and lifestyle confounders. In stratified analyses, we also estimated FR with 95% CI in relation to FA supplementation for women with regular and irregular cycles, respectively, and for women with short (<27 days), medium (27-29 days) and long cycles (⩾30 days), respectively. RESULTS: FA supplementation was associated with increased fecundability (FR=1.15, 95% CI=1.06-1.25), compared with non-use. The adjusted FRs for FA supplement use relative to non-use were 1.35 (95% CI=1.12-1.65) and 1.11 (95% CI=1.01-1.22) for women with irregular and regular cycles, respectively, and 1.36 (95% CI=0.95-1.95), 1.10 (95% CI=0.98-1.22) and 1.24 (95% CI=1.10-1.41) for women with short (<27 days), medium (27-29 days) and long cycles (⩾30 days), respectively. CONCLUSIONS: FA supplementation was associated with increased fecundability, and this association appeared to be stronger among women with irregular cycles and among women with either short or long cycle length.
Authors: Ellen M Mikkelsen; Elizabeth E Hatch; Lauren A Wise; Kenneth J Rothman; Anders Riis; Henrik Toft Sørensen Journal: Int J Epidemiol Date: 2008-09-09 Impact factor: 7.196
Authors: Vibeke K Knudsen; Lone B Rasmussen; Jóhanna Haraldsdóttir; Lars Ovesen; Inge Bülow; Nils Knudsen; Torben Jørgensen; Peter Laurberg; Hans Perrild Journal: Public Health Nutr Date: 2002-06 Impact factor: 4.022
Authors: Heidi T Cueto; Anders H Riis; Elizabeth E Hatch; Lauren A Wise; Kenneth J Rothman; Ellen M Mikkelsen Journal: Clin Epidemiol Date: 2012-10-05 Impact factor: 4.790
Authors: Amelia K Wesselink; Elizabeth E Hatch; Kenneth J Rothman; Sydney K Willis; Olivia R Orta; Lauren A Wise Journal: Environ Int Date: 2020-04-04 Impact factor: 9.621
Authors: Jennifer J Yland; Taiyao Wang; Zahra Zad; Sydney K Willis; Tanran R Wang; Amelia K Wesselink; Tammy Jiang; Elizabeth E Hatch; Lauren A Wise; Ioannis Ch Paschalidis Journal: Hum Reprod Date: 2022-03-01 Impact factor: 6.918
Authors: Mumta Kadir; Robert B Hood; Lidia Mínguez-Alarcón; Ana Belén Maldonado-Cárceles; Jennifer B Ford; Irene Souter; Jorge E Chavarro; Audrey J Gaskins Journal: Fertil Steril Date: 2021-11-19 Impact factor: 7.329
Authors: Heidi T Cueto; Bjarke H Jacobsen; Anne Sofie Dam Laursen; Anders H Riis; Elizabeth E Hatch; Lauren A Wise; Ellen Trolle; Henrik Toft Sørensen; Kenneth J Rothman; Amelia K Wesselink; Sydney Willis; Benjamin R Johannesen; Ellen M Mikkelsen Journal: Hum Reprod Date: 2022-04-01 Impact factor: 6.918